Tsc2 expression increases the susceptibility of renal tumor cells to apoptosis.

Although the precise role for the tuberous sclerosis complex-2 tumor suppressor gene (Tsc2) in tumor suppression is not clear, many studies have implicated Tsc2 in the regulation of cell differentiation, cell cycle control, GTPase activity, transcription, polycystin-1 localization, and translation initiation. We propose that Tsc2 also increases susceptibility to apoptosis, and that this functional role may contribute to the tumor suppressor activity of Tsc2. We previously characterized the apoptotic response of a Tsc2-null renal tumor cell line (ERC-18) to the tumor promoter okadaic acid (OKA). In the present study, we expressed Tsc2 in ERC-18 cells and compared the effect of Tsc2 expression on apoptotic induction. Tsc2 expression increased the susceptibility of ERC-18 cells to apoptosis induced by OKA and the phosphatidylinositol-3' kinase inhibitor, LY294002. In addition, Tsc2 expression abrogated OKA-induced cell detachment of ERC-18 cells. These results indicate that the OKA-induced, caspase-independent detachment previously observed in ERC-18 cells is Tsc2-dependent, and may support an additional role for the Tsc2 in regulating cell adhesion.

[1]  K. Inoki,et al.  TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling , 2002, Nature Cell Biology.

[2]  G. Evan,et al.  Proliferation, cell cycle and apoptosis in cancer , 2001, Nature.

[3]  B. Trump,et al.  Differential sensitivity of normal and H-ras oncogene-transformed rat kidney epithelial cells to okadaic acid-induced apoptosis. , 1996, Toxicology and applied pharmacology.

[4]  H. Onda,et al.  Tuberous Sclerosis Gene 2 Product Modulates Transcription Mediated by Steroid Hormone Receptor Family Members* , 1998, The Journal of Biological Chemistry.

[5]  T. Goldsworthy,et al.  Predisposition to renal cell carcinoma due to alteration of a cancer susceptibility gene. , 1992, Science.

[6]  J. Declue,et al.  Identification of Tuberin, the Tuberous Sclerosis-2 Product. TUBERIN POSSESSES SPECIFIC Rap1GAP ACTIVITY (*) , 1995, The Journal of Biological Chemistry.

[7]  E. Henske,et al.  Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis. , 2001, American journal of respiratory and critical care medicine.

[8]  T. Goldsworthy,et al.  Rodent model of reproductive tract leiomyomata. Establishment and characterization of tumor-derived cell lines. , 1995, The American journal of pathology.

[9]  C. Walker,et al.  Carcinogenicity of a nephrotoxic metabolite of the "nongenotoxic" carcinogen hydroquinone. , 2001, Chemical research in toxicology.

[10]  T. Goldsworthy,et al.  Hereditary renal cell carcinoma in the Eker rat: a rodent familial cancer syndrome. , 1992, The Journal of urology.

[11]  A. Knudson,et al.  Spontaneous and radiation-induced renal tumors in the Eker rat model of dominantly inherited cancer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Declue,et al.  Role of the Tuberous Sclerosis Gene-2 Product in Cell Cycle Control , 1997, The Journal of Biological Chemistry.

[13]  O. Hino,et al.  Tsc tumour suppressor proteins antagonize amino-acid–TOR signalling , 2002, Nature Cell Biology.

[14]  T. Hunter,et al.  Oncogenic kinase signalling , 2001, Nature.

[15]  C. Walker,et al.  Increased susceptibility to in vitro transformation of cells carrying the Eker tumor susceptibility mutation. , 1994, Carcinogenesis.

[16]  Tian Xu,et al.  Akt regulates growth by directly phosphorylating Tsc2 , 2002, Nature Cell Biology.

[17]  S. R. Datta,et al.  Cellular survival: a play in three Akts. , 1999, Genes & development.

[18]  J. Sampson,et al.  A cross sectional study of renal involvement in tuberous sclerosis. , 1996, Journal of medical genetics.

[19]  Elizabeth Yang,et al.  Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL , 1996, Cell.

[20]  R. Snell,et al.  Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. , 1998, Human molecular genetics.

[21]  T. Goldsworthy,et al.  Hereditary renal cell carcinoma in the Eker rat: a unique animal model for the study of cancer susceptibility. , 1995, Toxicology Letters.

[22]  T. Kolb,et al.  The tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA) provokes a prolonged morphologic response and ERK activation in Tsc2-null renal tumor cells. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  B. Edgar,et al.  Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins , 2003, Nature Cell Biology.

[24]  S. Thomas,et al.  Identification and characterization of the tuberous sclerosis gene on chromosome 16 , 1993, Cell.

[25]  L. Aicher,et al.  Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. , 2002, Cancer research.

[26]  A. Knudson,et al.  Genetic predisposition to transplacentally induced renal cell carcinomas in the Eker rat. , 1993, Cancer research.

[27]  M. Mann,et al.  p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Yeung,et al.  Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[30]  S. Nicosia,et al.  Phosphatidylinositol 3-Kinase/Akt Pathway Regulates Tuberous Sclerosis Tumor Suppressor Complex by Phosphorylation of Tuberin* , 2002, The Journal of Biological Chemistry.

[31]  David J. Kwiatkowski,et al.  Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Smith,et al.  Characterization of a Renal Epithelial Cell Model of Apoptosis Using Okadaic Acid and the NRK-52E Cell Line , 1994, Toxicologic pathology.

[33]  G. Landes,et al.  Tuberin-dependent membrane localization of polycystin-1: a functional link between polycystic kidney disease and the TSC2 tumor suppressor gene. , 2001, Molecular cell.

[34]  O. Hino,et al.  Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model. , 1996, Cancer research.

[35]  John Calvin Reed,et al.  Regulation of cell death protease caspase-9 by phosphorylation. , 1998, Science.

[36]  T. Goldsworthy,et al.  Estrogen treatment enhances hereditary renal tumor development in Eker rats. , 1998, Carcinogenesis.

[37]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[38]  E. Henske,et al.  Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration , 2002, Oncogene.

[39]  T. Kolb,et al.  Biochemical and Morphological Events During Okadaic Acid-Induced Apoptosis of Tsc2-Null ERC-18 Cell Line , 2002, Toxicologic pathology.

[40]  Y. Nabeshima,et al.  Identification of the coding sequences responsible for Tsc2-mediated tumor suppression using a transgenic rat system. , 2002, Human Molecular Genetics.

[41]  L. Truong,et al.  Apoptosis in renal cell carcinoma: detection by in situ end-labeling of fragmented DNA and correlation with other prognostic factors. , 1996, Human pathology.

[42]  E. Golemis,et al.  The Tuberous Sclerosis 2 Gene Product, Tuberin, Functions as a Rab5 GTPase Activating Protein (GAP) in Modulating Endocytosis* , 1997, The Journal of Biological Chemistry.

[43]  T. Vanaman,et al.  A calmodulin binding site in the tuberous sclerosis 2 gene product is essential for regulation of transcription events and is altered by mutations linked to tuberous sclerosis and lymphangioleiomyomatosis. , 2002, Archives of biochemistry and biophysics.

[44]  E. Henske,et al.  Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Declue,et al.  Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[46]  D. Kwiatkowski,et al.  Tuberin Regulates p70 S6 Kinase Activation and Ribosomal Protein S6 Phosphorylation , 2002, The Journal of Biological Chemistry.

[47]  M. Davis,et al.  Herbimycin A and geldanamycin inhibit okadaic acid-induced apoptosis and p38 activation in NRK-52E renal epithelial cells. , 1999, Toxicology and applied pharmacology.